SLAMF6作为药物向性抑制T细胞免疫力对抗癌症的抑制剂
Bin Li1,2,3, Ming-Chao Zhong1, Cristian Camilo Galindo1,3
1Laboratory of Molecular Oncology, Institut de recherches cliniques de Montréal (IRCM), Montreal, Quebec, Canada.
Nature
|February 11, 2026
概括
信号淋巴细胞激活分子6 (SLAMF6) 通过cis相互作用抑制T细胞抗瘤活性. 阻断SLAMF6可以增强T细胞的功能,减少瘤的生长,并将其确定为有前途的免疫疗法标.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子生物学分子生物学
背景情况:
- 免疫检查点抑制剂如PD-1和CTLA-4在癌症治疗中至关重要.
- 信号淋巴细胞激活分子6 (SLAMF6) 在T细胞功能中具有模两可的作用.
- SLAMF6在原始耗尽的T细胞 (Tpex) 上表达,这些T细胞保留了功能恢复能力.
研究的目的:
- 阐明SLAMF6在T细胞介导的抗瘤免疫中的确切作用.
- 研究SLAMF6激活的机制及其功能后果.
- 评估SLAMF6作为癌症免疫治疗的潜在治疗标.
主要方法:
- 使用小鼠模型研究T细胞中的SLAMF6功能.
- 使用单克隆抗体 (mAbs) 来阻止SLAMF6的 cis相互作用.
- 在体内评估T细胞激活,耗尽标志物和瘤生长.
主要成果:
- 通过同型相互作用在cis中触发SLAMF6,抑制T细胞激活.
- 对T细胞的SLAMF6抑制发生的独立于瘤细胞的表达.
- 抗SLAMF6mAbs增强了T细胞激活,减少了T细胞耗尽,并抑制了瘤生长.
结论:
- SLAMF6仅作为T细胞抑制受体,通过cis同型相互作用激活.
- 准SLAMF6为增强抗瘤免疫提供了一个新的策略.
- 无论瘤细胞的SLAMF6表达如何,SLAMF6是癌症免疫疗法的有希望的治疗标.
相关概念视频
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
9.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:26Targets for Drug Action: Overview
10.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.5K
01:29Pharmacogenomics: Identification of New Drug Targets
2
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
2
01:38What is the Immune System?
132.4K
Overview
132.4K
01:36Humoral Immune Responses
84.1K
Overview
84.1K